Qutenza plus standard of care versus standard of care alone for painful diabetic peripheral neuropathy

Phase 3, randomised, open-label trial in diabetic polyneuropathy (DPN) comparing Qutenza plus standard of care with Standard of care alone (2 arms). Primary endpoint: Percentage change in health related quality of life total score. Started May 2011; status: completed.